Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151998 | SCV000200557 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Pro323Pro in exon 2 of TERT: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 0.5% (21/4194) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs148549782). |
Labcorp Genetics |
RCV002516058 | SCV000291884 | benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000151998 | SCV002068450 | benign | not specified | 2021-03-05 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256087 | SCV002533165 | likely benign | Dyskeratosis congenita | 2021-06-24 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002256087 | SCV002690565 | likely benign | Dyskeratosis congenita | 2022-05-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003315941 | SCV004015604 | benign | Acute myeloid leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003457647 | SCV004185254 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | TERT: BP4, BP7 |
Breakthrough Genomics, |
RCV003457647 | SCV005305546 | benign | not provided | criteria provided, single submitter | not provided |